Insider sales and purchases reported this week
Sales and purchases (SEC codes S and P, open-market or private) by officers, directors and 10% owners of the companies on this site (US IPOs from 2024 to 2026), filed with the SEC on Form 4 from Nov 8, 2026 to Nov 14, 2026. Largest value first, up to 25; one row per filing and type, with shares and value summed over the filing's transactions. Names and roles are shown as filed.
Filings from Nov 8, 2026 to Nov 14, 2026
| Company | Type (SEC code) | Value | Shares | Insider | Trade date | Filed | Filing |
|---|---|---|---|---|---|---|---|
| MANEVeraDermics, Inc | Sale (S) | $75.2M | 500,000 | Longitude Capital Partners V, LLC10% owner | Nov 11, 2026 | Nov 13, 2026 | sec.gov |
| CHYMChime Financial, Inc. | Sale (S) | $41.4M | 1,329,767 | DST Global Advisors Ltd10% owner | Nov 6, 2026 | Nov 9, 2026 | sec.gov |
| CTRICenturi Holdings, Inc. | Sale (S) | $33.7M | 1,500,433 | ICAHN CARL C10% owner | Nov 12, 2026 | Nov 13, 2026 | sec.gov |
| HNGEHinge Health, Inc. | Sale (S) | $24.5M | 200,000 | Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | Nov 11, 2026 | Nov 12, 2026 | sec.gov |
| IBTAIbotta, Inc. | Sale (S) | $16.4M | 275,000 | KDT Ibotta Holdings, LLC10% owner | Nov 12, 2026 | Nov 13, 2026 | sec.gov |
| IBTAIbotta, Inc. | Sale (S) | $11.7M | 200,000 | KDT Ibotta Holdings, LLC10% owner | Nov 10, 2026 | Nov 12, 2026 | sec.gov |
| IBTAIbotta, Inc. | Sale (S) | $11.6M | 200,000 | KDT Ibotta Holdings, LLC10% owner | Nov 6, 2026 | Nov 9, 2026 | sec.gov |
| NPNeptune Insurance Holdings Inc. | Sale (S) | $7.31M | 260,000 | Duffy Matthew PaulPresident & Chief Risk Officer, Positions held at subsidiary | Nov 11, 2026 | Nov 12, 2026 | sec.gov |
| AVLNAvalyn Pharma Inc. | Sale (S) | $6.7M | 228,454 | FMR LLC10% owner, Other | Nov 10, 2026 | Nov 12, 2026 | sec.gov |
| VGVenture Global, Inc. | Sale (S) | $6.58M | 500,000 | Musser ForySenior VP, Development | Nov 12, 2026 | Nov 13, 2026 | sec.gov |
| NPNeptune Insurance Holdings Inc. | Sale (S) | $4.75M | 171,285 | Burgess Trevor RDirector, Chief Executive Officer, 10% owner | Nov 6, 2026 | Nov 9, 2026 | sec.gov |
| HNGEHinge Health, Inc. | Sale (S) | $4.37M | 35,907 | Budge JamesChief Financial Officer | Nov 10, 2026 | Nov 12, 2026 | sec.gov |
| TBBBBBB FOODS INC | Sale (S) | $4.1M | 60,000 | Hatoum Kamal AnthonyDirector, Chairman & CEO | Nov 13, 2026 | Nov 13, 2026 | sec.gov |
| CRCLCircle Internet Group, Inc. | Sale (S) | $4.06M | 59,237 | Allaire JeremyDirector, Chairman and CEO | Nov 5, 2026 | Nov 9, 2026 | sec.gov |
| SEPNSepterna, Inc. | Sale (S) | $3.93M | 81,820 | Ezekowitz AlanDirector | Nov 11, 2026 | Nov 13, 2026 | sec.gov |
| XHLDTEN Holdings, Inc. | Sale (S) | $3.01M | 322,738 | V-Cube, Inc.10% owner | Sep 3, 2026 | Nov 13, 2026 | sec.gov |
| ALMRAlamar Biosciences, Inc. | Sale (S) | $2.94M | 100,117 | Qiming Corporate GP VI, Ltd.10% owner | Nov 11, 2026 | Nov 13, 2026 | sec.gov |
| ALABAstera Labs, Inc. | Sale (S) | $2.64M | 12,499 | Dyckerhoff Stefan ADirector | Nov 5, 2026 | Nov 9, 2026 | sec.gov |
| WAYWaystar Holding Corp. | Sale (S) | $2.37M | 82,500 | Hawkins Matthew J.Director, Chief Executive Officer | Nov 10, 2026 | Nov 10, 2026 | sec.gov |
| HTFLHeartflow, Inc. | Sale (S) | $2.17M | 38,900 | Farquhar John C.M.Director, Chief Executive Officer | Nov 10, 2026 | Nov 10, 2026 | sec.gov |
| PACSPACS Group, Inc. | Sale (S) | $2M | 40,000 | Jergensen JoshuaPresident & COO | Nov 11, 2026 | Nov 12, 2026 | sec.gov |
| CRCLCircle Internet Group, Inc. | Sale (S) | $1.76M | 26,668 | Chandhok NikhilChief Product & Tech. Officer | Nov 9, 2026 | Nov 10, 2026 | sec.gov |
| MRXMarex Group Ltd | Sale (S) | $1.49M | 22,456 | Van Den Born SimonPresident | Nov 5, 2026 | Nov 9, 2026 | sec.gov |
| ARXSArxis, Inc. | Sale (S) | $1.27M | 25,000 | Perhamus Kevin ScottDirector, Officer | Nov 9, 2026 | Nov 12, 2026 | sec.gov |
| MRXMarex Group Ltd | Sale (S) | $1.14M | 16,668 | Tonucci PaoloOfficer | Nov 9, 2026 | Nov 12, 2026 | sec.gov |
Sale (S): open-market or private sale. Purchase (P): open-market or private purchase. The SEC's codes also cover private transactions, such as sales into an underwritten secondary offering. Value is shares times the reported price where the filing gives one. Trade date: the latest transaction in the filing.
What Form 4 shows
Officers, directors and holders of more than 10% of a company's shares must report every change in their holdings to the SEC on Form 4, usually within two business days (section 16 of the Securities Exchange Act). The filings are public. After the lock-up expires, people who held shares before the IPO may sell; sales by officers, directors and 10% owners appear on Form 4.
Each company page has an Insider transactions card: totals of sales and purchases (SEC codes S and P, open-market or private, without rows in the IPO) since the IPO, since the lock-up and over the last 30 days, and the latest transactions with the type and SEC code, the insider's name and role as filed, shares, price, value, shares owned afterwards and a link to the filing on sec.gov. Option exercises, shares withheld for tax or exercise price, grants and gifts are listed with their type but are not counted as sales or purchases.
Form 4 shows what insiders reported, not why. Sales can have many reasons, such as paying taxes or diversifying. A sale marked 10b5-1 is one the filing reports as made under a pre-arranged trading plan (Rule 10b5-1); IPO Arc does not see the plan or check its terms. This is information, not a research signal: no IPO Arc rule uses it, and a rule based on it would first have to pass the same tests as the research rules.
Limits of the data
- Lag and late filings: Form 4 is due two business days after the transaction; some filings arrive later. Totals on company pages count by transaction date and the weekly list by filing date, so a late filing can add to a past window.
- Amendments: A corrected filing (Form 4/A) replaces the filing it amends, or only the rows it corrects, when the two can be matched by rule. An unusual amendment that cannot be matched may be counted next to its original.
- Indirect holdings and repeated reports: Shares held through trusts, funds or family members are reported as indirect. One economic sale can appear under several related owners (a fund, its general partner, a director it appoints); repeated reports are counted once only when the rows are identical. Sellers and buyers count distinct first reporting owners.
- Names and attribution: Names and roles are shown as filed with the SEC, usually surname first. A joint filing is shown under its first reporting owner, and a transaction reported by several related owners appears once, under the owner of the earliest filing. A name next to an indirect holding does not mean that the person owns those shares personally. The linked filing on sec.gov lists every reporting owner and its footnotes.
- 10b5-1 marks: A transaction is marked 10b5-1 when a footnote attached to it mentions a pre-arranged trading plan (Rule 10b5-1). When no row of a filing has such a footnote, the filing's 10b5-1 check box, its remarks or another footnote that mentions the rule mark all its sales and purchases. A missing mark does not mean that there was no plan.
- Prices: Many filers report a weighted average of several trades. Some give the price only in a footnote or an exhibit; the value is then unknown and the shares still count. A price above 100 times the offer price is treated as unknown (usually the total value typed into the price field); the shares still count. Prices of 0 are treated as unknown too.
- Transactions in the offering: Rows labelled “in the IPO” are left out of the totals and the weekly list: purchases at the offer price within 7 days of pricing (IPO allocations, concurrent private placements), sales at 90% to 100% of the offer price within 3 business days of pricing (selling stockholders at the closing), and sales within 35 days at the offer price or at the offer price less the underwriting discount in the prospectus (the over-allotment; 92.5% to 95% of the offer price when the discount is not found). The rule uses only price, date and the prospectus discount and can misclassify a trade.
- Not covered: Form 144 (a notice of a proposed sale, not a transaction), Form 3 (initial holdings), Form 5 (annual, exempt transactions), Schedules 13D and 13G, and holders below 10% who are not officers or directors.
- Foreign private issuers: Foreign private issuers are exempt from section 16 of the Securities Exchange Act, so their insiders file no Form 4. An empty list for such a company means “not required to report”, not “no trading”.
- Company identifiers: Filings are matched to each IPO by the company's SEC identifier (CIK); a company that later changed its CIK, for example in a reorganisation, may miss filings, and a company whose CIK was not found is shown as not matched yet.
Source: SEC EDGAR, Form 4 and 4/A ownership filings (public). IPO Arc is not affiliated with the SEC. Data through Nov 14, 2026.